• Clinical development and access issues in rare diseases

  The second day of the Orphan Drugs and Rare Diseases 2019 Conference focused on different...
  Read More...

• AAD 2019: S. aureus discussed as biomarker for atopic dermatitis

  New data from trials testing the efficacy and safety of Asana Bioscience’s ASN002, the first...
  Read More...

• Christensella: the key to unlocking gut microbiome-based drug discovery?

  LNC Therapeutics recently signed an agreement with Cornell University for its Christensenella patent, a recently...
  Read More...

• A big future awaits small-size antibodies

  Nanobodies are composed of the target-binding fragments of monoclonal antibodies; they are significantly smaller in...
  Read More...

• Trump administration proposal may neuter America’s tapeworm PBMs

  The United States Department of Health and Human Services has proposed new limitations on pharmacy...
  Read More...

• Pharma Technology Focus: Scottish pharma gets a health check

  In this issue: the disappearing supply of pink Migraleve in the UK, drug ingredients sourced...
  Read More...

• The Petri dish: telling the story of pharma’s most humble ally

  Well known to anyone familiar with a science classroom, the Petri dish has been used...
  Read More...

• World Cancer Day 2019: the oncology pricing debate continues

  This year’s World Cancer Day occurs on 4 February, which also marks the launch of...
  Read More...

• How to prevent contamination in a biopharmaceutical manufacturing operation

  Unlike traditional pharmaceuticals, biopharmaceuticals are a result of the genetic manipulation of living cells. Developing...
  Read More...

• Should pharmaceutical manufacturers invest in single-use containment?

  In an industry where safety is of the utmost importance ILC Dover’s single-use systems offer...
  Read More...